Member biographies: Advisory Committee on Human Pathogens and Toxins

From: Public Health Agency of Canada

Dr. Margo Moore (Chair)

Margo Moore completed her PhD in Pharmacology at the University of British Columbia followed by post-doctoral studies in Toxicology at the Karolinska Institute. She has been a professor at Simon Fraser University since 1990 where she teaches microbiology and runs a research program on fungal pathogenesis. She has chaired the SFU biosafety committee since 2005.

Ms. Ingrid Abbott-Permell

Ingrid Abbott-Permell is a Certified Biosafety Professional (CBSP) with ABSA international and a Specialist Microbiologist-Biological Safety with the National Registry of Certified Microbiologists (SM [NRCM]). She has over twenty-five years of experience in the development, implementation and monitoring of biorisk management systems in public health, research and development as well as vaccine manufacturing facilities. (Containment Level 2 and Containment Level 3 Laboratories, Small Animal Facilities and Containment Level 2 Large scale facilities) She is a certified trainer and has developed and delivered biosafety courses as well as certification courses on the Transportation of Dangerous Goods Class 6.2 Infectious Substances.

Ingrid has contributed to the international biosafety community in several capacities. She is an active member of ABSA international and has served as co-chair and member of the Technical Review Committee and also as a member of the Pre-Conference Course Committee. She has served as a Mentor/ International Biorisk Management Advisor on the Development and Twinning Program for Sandia National Laboratories' International Biological Threat Reduction Program (SNL/IBTR), a member of the Bi-National Working group on Laboratory Acquired Infections (US and Canada), has represented the province of Ontario on the Biosafety Officer Network, Canadian Public Health Laboratory Network and has co-authored several biosafety presentations at ABSA International annual Biosafety conferences (Winner of the International Poster Award 2011 - presentation on "Implementing Ergonomics in the Laboratory safety Program). Ingrid has also contributed to the validation of the Biosafety Risk Assessment Methodology (BIORAM) for Sandia National Laboratories USA.

Dr. Maurice Boissinot

Maurice Boissinot is a microbiologist having experience working in industry as well as in the academic world. He obtained a PhD in microbiology-immunology from Université Laval in 1989. He completed his post-doctoral training in California at the Scripps Research Institute and at Chiron Corporation. From 1996 to 1998, he acted as scientific director of BCM Oncologia, a small biotech company from Quebec City. Since 1998, he has been project leader in the molecular diagnostic group at the Infectious Diseases Research Center (CRI) of Université Laval, where he is working on the development of rapid tests for the detection and identification of pathogenic micro-organisms. He is also curator of the strain collection of more than 20 000 strains representing most human bacterial pathogens and several human viruses. He was a member of the team that developed the first two real-time PCR tests to be approved by the Food and Drug Administration (FDA). He was responsible to develop Bacillus anthracis and SARS-CoV rapid detection tests for Canadian military and civilian emergency responses programs. He is an author on over 70 scientific publications covering disciplines such as microbiology, chemistry, microfluidics, nanotechnology, and physics.

Mr. Kevin Cassidy

Mr. Kevin Cassidy, Vice President, Biopharmaceuticals, Microbix Biosystems Inc. has over 30 years in biopharmaceutical, vaccine and medical device experience. That experience includes culture of numerous virus and bacterial species at industrial scale for use in manufacture of human diagnostic medical devices. He is also a specialist in building capability to bring new products through development to market. He has detailed knowledge of industrial development and manufacturing of biopharmaceuticals.

Dr. Andrew Doxey

Dr. Andrew Doxey is a bioinformatician and Associate Professor in the Department of Biology at the University of Waterloo, where he holds a University Research Chair. He is cross-appointed to the School of Computer Science, and is also an adjunct Professor in the Department of Medicine at McMaster University. The Doxey lab focuses on bioinformatics, microbial genomics, and molecular evolution, and applies computational methods to discover new protein families and functions. Recent work includes the development of the AnnoTree phylogenomics database, and studies on the evolution and diversity of bacterial toxins such as botulinum, diphtheria, and C. difficile toxins. Dr. Doxey is supported by grants from NSERC and MITACS, and is the recipient of the 2018 Thermo Fisher Award for contributions to microbiology.

Ms. Joy Kearsey

Joy Kearsey completed her MSc in Microbiology and Immunology at Dalhousie University. She has prior hands-on experience in academia, industry, and the RCMP forensic laboratories. Since 2014, she has been the biosafety officer (BSO) for Nova Scotia Health and the IWK Health Centre, which includes both CL2 and CL3 laboratories. She is a Registered Biological Safety Officer with the Canadian Association for Biological Safety and is a member of several BSO communities, including a network for biosafety officers in the Atlantic provinces which she founded.

Dr. Ayush Kumar

Ayush Kumar is an Associate Professor of Microbiology at the University of Manitoba. Dr. Kumar completed his PhD in Microbiology from the University of Manitoba. He did his post-doctoral work at Colorado State University's Rocky Mountain Regional Center for Excellence where he studied multidrug resistance mechanisms in bacterial pathogens classified as Select Agents. At the University of Manitoba, Dr. Kumar laboratory studies multidrug resistance mechanisms in Acinetobacter baumannii and Pseudomonas aeruginosa. His group is also studying the prevalence of antimicrobial resistance genes in source and drinking water from First Nations communities in Manitoba.

Dr. Paul Levett

Dr. Paul Levett is a clinical microbiologist at the British Columbia Centre for Disease Control in Vancouver. He was formerly the Clinical Director of the Saskatchewan Disease Control Laboratory, and has significant experience in design and operation of CL3 laboratories. His research interests are in applied public health microbiology, and leptospirosis. He has also published numerous articles concentrating on diagnostic and epidemiological studies of zoonoses, including leptospirosis and West Nile virus.

Dr. Momar Ndao

Dr. Momar Ndao is a Professor at McGill University in the Department of Medicine, Division of Infectious Diseases and Director of the Canadian National Reference Centre for Parasitology (NRCP) since 2002. He completed his veterinary studies in Senegal and Diploma in Tropical Medicine, MSc and PhD in International Health and Tropical Diseases at the Institute of Tropical Medicine in Antwerp. Dr. Ndao is actively involved in 1) bringing cutting edge science to diagnose infectious diseases; 2) studying host-parasite interactions; 3) screening drugs to be used as therapies for infectious diseases; 4) developing vaccines to prevent parasitic diseases and 5) applying proteomic technology to discover biomarkers for infectious diseases.

Dr. John Prescott

John F. Prescott is a retired University Professor Emeritus from the University of Guelph, where he was Chair, Department of Pathobiology, 2003-2018. He has very diverse interests in bacterial infections in animals, but is best known for work on Rhodococcus equi pneumonia in foals and in promoting better use of antimicrobial drug use in animals. He is the originator, editor and an author of the text "Antimicrobial Therapy in Veterinary Medicine", now in its fifth edition. More recent research interests are in understanding necrotic enteritis of broiler chickens, and on the role of Clostridium perfringens in other serious intestinal infections of animals. He was elected a Fellow of the Canadian Academy of Health Sciences in 2008.

Dr. James Scott

Dr. James Scott is Professor, Dalla Lana School of Public Health at the University of Toronto and Head of the Division of Occupational and Environmental Health. Since his appointment in 2002, his chief academic interest has been the recognition, evaluation and control of biological hazards, particularly bioaerosols, in the workplace and community. He is also the owner of Sporometrics Inc, an ISO/IEC17025 accredited commercial environmental microbiology diagnostic laboratory.

Dr. Fiona Smaill

Dr Fiona Smaill is Professor in the Department of Pathology and Molecular Medicine in the Faculty of Health Sciences, McMaster University and a Medical Microbiologist for the Hamilton Regional Laboratory Medicine Program. She is a consultant in Infectious Diseases, co-director of the HIV clinic at Hamilton Health Sciences and an active teacher and researcher. Dr. Smaill has her MB ChB from the University of Otago in New Zealand, completed her residencies in Internal Medicine, Infectious Diseases, and Medical Microbiology at McMaster University and has her MSc in Epidemiology. Her research involves clinical trials in HIV, new vaccines for tuberculosis, and systematic reviews on infections in pregnancy.

Dr. Manal Tadros

Manal Tadros MBBS, MSc, PhD, FRCPC, graduated from Medical School at Cairo University. She received her MSc and PhD degrees from Cairo University in Clinical Pathology, with Medical Microbiology as her subspecialty. She worked as a Medical Microbiologist and Infection Control Consultant at Cairo University Hospitals. She moved to Canada in 2005 and after obtaining her Medical Council of Canada certification, Dr. Tadros joined the residency program at University of Toronto Medical Microbiology department for re-training. She obtained her Royal College certification in 2013. She worked as a Medical Microbiologist and Site Director of Infection Control at Fraser Health Authority, British Columbia from October 2013 until June 2015. She joined St. Michael 's Hospital in July 2015 and has been working as a Medical Microbiologist and the Laboratory Biosafety Advisor at St. Michael's Hospital since then. She is also an Assistant Professor of Laboratory Medicine at University of Toronto. Dr. Tadros' research interests are in the area of antimicrobial resistance, hospital epidemiology, improving diagnostics in the medical microbiology laboratory and other quality improvement initiatives.

Page details

Date modified: